Omeros (OMER) Cash from Financing Activities (2010 - 2026)

Omeros' (OMER) quarterly Cash from Financing Activities came in at -$22.0 million in Q1 2026, down 1095.32% year-on-year from $2.2 million in Q1 2025, and up 65.89% quarter-over-quarter from -$64.4 million in Q4 2025.

Omeros (OMER) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Omeros has disclosed Cash from Financing Activities across 17 years of filings, most recently posting -$22.0 million for Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$22.0 million, down 1095.32% year-over-year; the trailing twelve-month figure through Mar 2026 was -$62.3 million (down 66.66% YoY), and the FY2025 annual result was -$42.2 million, down 167.06% from the prior year.
  • Cash from Financing Activities came in at -$22.0 million for Q1 2026 at Omeros, up from -$64.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $124.8 million in Q3 2022 to a low of -$105.0 million in Q4 2023.
  • The 5-year median for Cash from Financing Activities is -$651000.0 (2022), against an average of $993764.7.
  • Across the five-year window, Cash from Financing Activities jumped 26016.53% in 2022 and slumped 16021.81% in 2023, its largest moves.
  • Omeros' Cash from Financing Activities stood at -$651000.0 in 2022, then plunged by 16021.81% to -$105.0 million in 2023, then jumped by 96.1% to -$4.1 million in 2024, then tumbled by 1473.6% to -$64.4 million in 2025, then jumped by 65.89% to -$22.0 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$22.0 million (Q1 2026), -$64.4 million (Q4 2025), and $25.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 7.00 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -600,000.00
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 53,000.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -538.80 Mn
9 Abivax 90.15 Bn 90.15 Bn - 85,464.43
10 Omeros 628.56 Mn 493.24 Mn 9.31 Mn -21.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -21.98 Mn
Mar 31, 2026 -21.98 Mn
Dec 31, 2025 -64.44 Mn
Dec 31, 2025 -64.44 Mn
Sep 30, 2025 25.83 Mn
Sep 30, 2025 25.83 Mn
Jun 30, 2025 -1.72 Mn
Jun 30, 2025 -1.72 Mn
Mar 31, 2025 -1.84 Mn
Mar 31, 2025 -1.84 Mn
Dec 31, 2024 -4.10 Mn
Dec 31, 2024 -4.10 Mn
Sep 30, 2024 -4.58 Mn
Sep 30, 2024 -4.58 Mn
Jun 30, 2024 -26.88 Mn
Jun 30, 2024 -26.88 Mn
Mar 31, 2024 98.43 Mn
Mar 31, 2024 98.43 Mn
Dec 31, 2023 -104.95 Mn
Dec 31, 2023 -104.95 Mn